title: Effects of symptomatic treatments on cutaneous hyperalgesia and laser evoked potentials during migraine attack.
abstract: Previously an amplitude enhancement of laser evoked potentials (LEPs) was detected during migraine attack: we further examined pain threshold to CO2 laser stimuli and LEPs during attacks, evaluating the effect of almotriptan, lysine-acetylsalicylate and placebo treatment on cutaneous hyperalgesia to thermal stimuli delivered by CO2 laser and on LEP components. Eighteen patients suffering from migraine without aura were analysed. They were divided into three groups of six patients each, randomly assigned to lysine acetyl-salicylate, almotriptan or placebo treatments. The supraorbital zones and the dorsum of the hand were stimulated on both the symptomatic and not symptomatic side in all patients. The LEPs were recorded by 25 scalp electrodes. During attacks, the P2 wave was significantly enhanced; the amplitude of the P2 component obtained by the stimulation of the supraorbital zone during the attack on the side of the headache was significantly correlated with the intensity of pain and the frequency of headache. Both almotriptan and lysine acetyl-salicylate significantly reduced the P2 amplitude but they showed no effects on hyperalgesia to laser stimulation; headache relief following therapy was correlated with the reduction of the P2 amplitude. The cortical elaboration of laser-induced experimental pain seemed increased during migraine attack, and the severity of headache was mainly related to the increase of the later LEPs components expressing the attentive and emotive compounds of suffering. Reversion of this process appeared to be primarily responsible for the efficacy of drugs in treating migraine, though both almotriptan and lysine-acetil salicilate seemed to have no effect in reducing sensitization at second and third order nociceptive neurons.
authors.affiliation: Laboratory of Clinical Neurophysiology and Pain, Department of Neurologic and Psychiatric Sciences, University of Bari, Policlinico, Piazza Giulio Cesare, Bari Italy. m.detommaso@neurol.uniba.it
authors.forename: M
authors.initials: M
authors.lastname: de Tommaso
authors.forename: L
authors.initials: L
authors.lastname: Losito
authors.forename: G
authors.initials: G
authors.lastname: Libro
authors.forename: M
authors.initials: M
authors.lastname: Guido
authors.forename: O
authors.initials: O
authors.lastname: Di Fruscolo
authors.forename: M
authors.initials: M
authors.lastname: Sardaro
authors.forename: V
authors.initials: V
authors.lastname: Sciruicchio
authors.forename: P
authors.initials: P
authors.lastname: Lamberti
authors.forename: P
authors.initials: P
authors.lastname: Livrea
mesh_terms: D000328:Adult; D001241:Aspirin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005071:Evoked Potentials / Q000187:drug effects / Q000502:physiology*; D005260:Female; D006358:Hot Temperature; D006801:Humans; D006930:Hyperalgesia / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D007211:Indoles / Q000627:therapeutic use; D007834:Lasers; D008239:Lysine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008875:Middle Aged; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D014363:Tryptamines
chemical_list: D007211:Indoles; D014363:Tryptamines; C409045:almotriptan; D008239:Lysine; D001241:Aspirin; C010395:acetylsalicylic acid lysinate